Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Innovations and challenges in melanoma: summary statement from the first Cambridge conference.
Atkins MB, Elder DE, Essner R, Flaherty KT, Gajewski TF, Haluska FG, Hwu P, Keilholz U, Kirkwood JM, Mier JW, Ross MI, Slingluff CL, Sondak VK, Sosman JA, Weinstock MA, King L. Atkins MB, et al. Among authors: sondak vk. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2291s-2296s. doi: 10.1158/1078-0432.CCR-05-2560. Clin Cancer Res. 2006. PMID: 16609047
Complete spontaneous regression of pulmonary metastatic melanoma.
Wang TS, Lowe L, Smith JW 2nd, Francis IR, Sondak VK, Dworzanian L, Finkelstein S, Slingluff CL Jr, Johnson TM. Wang TS, et al. Among authors: sondak vk. Dermatol Surg. 1998 Aug;24(8):915-9. doi: 10.1111/j.1524-4725.1998.tb04275.x. Dermatol Surg. 1998. PMID: 9723062 Free article.
Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial.
Margolin KA, Liu PY, Unger JM, Fletcher WS, Flaherty LE, Urba WJ, Hersh EM, Hutchins LE, Sosman JA, Smith JW, Weiss GR, Sondak VK. Margolin KA, et al. Among authors: sondak vk. J Cancer Res Clin Oncol. 1999;125(5):292-6. doi: 10.1007/s004320050276. J Cancer Res Clin Oncol. 1999. PMID: 10359134 Free article. Clinical Trial.
Recent advances in melanoma staging and therapy.
McMasters KM, Sondak VK, Lotze MT, Ross MI. McMasters KM, et al. Among authors: sondak vk. Ann Surg Oncol. 1999 Jul-Aug;6(5):467-75. doi: 10.1007/s10434-999-0467-8. Ann Surg Oncol. 1999. PMID: 10458685 Free article. Review.
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.
Kirkwood JM, Ibrahim JG, Sosman JA, Sondak VK, Agarwala SS, Ernstoff MS, Rao U. Kirkwood JM, et al. Among authors: sondak vk. J Clin Oncol. 2001 May 1;19(9):2370-80. doi: 10.1200/JCO.2001.19.9.2370. J Clin Oncol. 2001. PMID: 11331315 Clinical Trial.
Interferon alfa-2a for melanoma metastases.
Kirkwood JM, Ibrahim JG, Sondak VK, Ernstoff MS, Ross M. Kirkwood JM, et al. Among authors: sondak vk. Lancet. 2002 Mar 16;359(9310):978-9. doi: 10.1016/S0140-6736(02)08001-7. Lancet. 2002. PMID: 11918944 No abstract available.
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group.
Sondak VK, Liu PY, Tuthill RJ, Kempf RA, Unger JM, Sosman JA, Thompson JA, Weiss GR, Redman BG, Jakowatz JG, Noyes RD, Flaherty LE. Sondak VK, et al. J Clin Oncol. 2002 Apr 15;20(8):2058-66. doi: 10.1200/JCO.2002.08.071. J Clin Oncol. 2002. PMID: 11956266 Clinical Trial.
457 results